What is the recommended postoperative follow‑up protocol after surgical treatment of Cushing's disease?

Postoperative Follow-Up of Cushing's Disease

Immediately after transsphenoidal surgery, measure morning serum cortisol on postoperative day 1, with a level <50 nmol/L (<1.8 μg/dL) indicating biochemical remission and predicting long-term success. 1

Immediate Postoperative Period (Days 1-14)

Biochemical Assessment:

• Measure serum cortisol the morning after surgery (postoperative day 1) to establish remission status
• Cortisol <50 nmol/L indicates hypocortisolism and successful remission with 99% remission rate at first follow-up 2
• Monitor serum sodium several times during the first 5-14 days to detect hyponatremia 1

Hormonal Evaluation:

• Assess free T4 and prolactin within 1-2 weeks to evaluate for overt hypopituitarism 1

Management Based on Cortisol Status:

• Hypocortisolism (cortisol <50 nmol/L): Start glucocorticoid replacement immediately with hydrocortisone and provide education about adrenal insufficiency, including stress dosing and medical alert identification 1
• Persistent hypercortisolism: Pursue additional treatments immediately (repeat surgery, medical therapy, or radiotherapy) 1
• Eucortisolism: Measure late-night salivary or serum cortisol to assess for subtle hypercortisolism 1

Early Follow-Up (1-3 Months)

• Obtain postoperative pituitary MRI within 1-3 months of successful surgery 1
• For patients on glucocorticoid replacement, begin assessing HPA axis recovery with morning cortisol levels (before that day's dose) every 3 months 1
• Consider ACTH stimulation testing when morning cortisol reaches ≥200 nmol/L (≥7.4 μg/dL); discontinue glucocorticoids when baseline or stimulated cortisol is ≥500 nmol/L (≥18 μg/dL) 1

Long-Term Surveillance Protocol

Lifelong monitoring is mandatory as recurrence can occur 10-15 years after apparent cure, even with initially undetectable postoperative cortisol. 3, 4

Annual Screening After HPA Axis Recovery:

• Late-night salivary cortisol (LNSC) is the most sensitive test for detecting recurrence and should be performed annually 4, 5
• LNSC becomes abnormal before dexamethasone suppression test (DST) and 24-hour urinary free cortisol (UFC) 4, 5
• Also perform 1-mg overnight dexamethasone suppression test and 24-hour UFC annually 1, 3

Follow-Up Intervals by Clinical Scenario (based on expert consensus 6):

• Remission on glucocorticoid replacement within 1 year of surgery: Every 8 weeks
• Uncontrolled persistent or recurrent disease: Every 4 weeks
• Post-radiotherapy patients controlled on medical therapy: Every 8-24 weeks
• After bilateral adrenalectomy with stable ACTH: Every 24 weeks

Special Considerations

Predictive Testing for Recurrence:

• Desmopressin testing at 3-6 months postoperatively can predict recurrence risk 7, 8
• Loss of desmopressin response after surgery suggests lower recurrence risk, while persistent response indicates higher risk 5, 8
• However, this testing is not universally recommended as some patients with low predicted risk still recur years later 4

Pituitary Function Reassessment:

• Re-evaluate all pituitary hormone deficiencies in the postoperative period 1
• Central hypothyroidism and hypogonadism may resolve after 6 months 1
• Growth hormone deficiency persists in >50% of children during the first 12 months 1

Management of Recurrence: If biochemical recurrence is detected:

• With visible tumor on MRI: Consider repeat transsphenoidal surgery, especially if initial surgery was not performed at a high-volume center 4
• Without visible tumor or after failed repeat surgery: Consider radiotherapy, medical therapy, or bilateral adrenalectomy through shared decision-making 1

Post-Bilateral Adrenalectomy Monitoring:

• Regularly evaluate for corticotroph tumor progression (Nelson's syndrome) using pituitary MRI and ACTH levels 1
• Monitor initially and at annual intervals, with frequency adjusted based on findings 1

Comorbidity Management:

• Treat cardiovascular risk factors, osteoporosis, and psychiatric symptoms throughout life until resolution 1

Critical Pitfalls to Avoid

• Never assume permanent cure: Recurrence can occur after 15+ years, necessitating truly lifelong surveillance 3
• Don't rely solely on UFC for recurrence detection: LNSC is more sensitive and detects recurrence earlier 4, 5
• Don't delay treatment of persistent hypercortisolism: If cortisol remains elevated postoperatively, initiate second-line therapy promptly 1
• Don't forget to reassess pituitary function: Hypopituitarism may improve over time, requiring periodic re-evaluation 1